455 — Tianda Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual balance sheet for Tianda Pharmaceuticals, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	HKAS	HKAS	HKAS	HKAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	443	306	235	349	162
Net Total Accounts Receivable
Net Total Receivables	80	92.8	148	145	105
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	720	594	606	577	344
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	95.6	211	379	436	413
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	997	933	1,133	1,164	917
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	178	145	214	272	313
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	220	210	377	407	325
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	777	723	757	757	592
Total Liabilities & Shareholders' Equity	997	933	1,133	1,164	917
Total Common Shares Outstanding